Fresh analysis suggests that people who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt conventional lifestyle regimens.
Published data in a major health publication shows that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.
"Users using such drugs should be aware of the risk of fast rebound weight gain when the therapy concludes," warns researcher Dr. Susan Jebb.
This pace of recovery implies a return to original weight in about 18 months.
Analyzing Treatments
The study, which examined dozens of studies involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists point out that individuals who lose weight through diet and exercise typically see a less rapid creep back—approximately 100 grams monthly—post-intervention.
Explaining the Rapid Rebound
Nutrition scientists believe the mode of action of the injections accounts for the amplified weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement means appetite is uncontrolled, making binge eating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts say that, given the significant potential of relapse, the therapy might need to be long-term.
This view is reinforced by drug manufacturers, who note that the findings "emphasize the long-term nature of obesity," akin to managing conditions like hypertension.
User Experiences
Users who have stopped the medication explain a powerful return of cravings.
"It was like something that goes on and you're instantly ravenous," recalled an individual.
The struggle is exacerbated if individuals have not established permanent dietary or behavioural changes during treatment.
Growing Interest
Figures indicate that millions of people in the UK have used these injections in the past year, with desire being substantial.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians stress that while the jabs are effective tools for shedding pounds, they are not a magic solution and long-term success relies on combined behavioural management.
